VBWG

6 related results for blockade


Core Curriculum

Progress and Promise in RAAS Blockade

View/Download individual slides (82 Slides)

New ACC/AHA Guidelines: Expanding the Role of Angiotensin Receptor Blockade in Heart Failure with LV Dysfunction

The 2005 ACC/AHA updated guidelines for the treatment of chronic HF and LV dysfunction in adults include an expanded role for ARBs as alternative therapy to ACEIs in selected patients and as added neurohormonal therapy in patients with persistent symptoms who are receiving optimal treatment.

Vascular Biology in Clinical Practice © Vol. 4, No. 5

The potential role of beta-blockade in blunting the progression of atherosclerosis

This monograph, The potential role of beta-blockade in blunting the progression of atherosclerosis , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.

MERIT-HF: Benefits of ß-blockade in women with heart failure and reduced left ventricular function

Under-representation of women in heart failure (HF) clinical trials has created uncertainty about the efficacy of various treatment strategies in women.

Angiotension type 1 receptor blockade versus ACE inhibition in the treatment of heart failure: Results of 3 clinical trials

Angiotension-converting enzyme (ACE) inhibitors are of critical importance for the treatment of patients with heart failure.

Data and Commentary: The BANFF Study

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease

J Am Coll Cardiol.